News from Kindred Biosciences, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Apr 18, 2018, 16:01 ET Kindred Biosciences to Announce First Quarter 2018 Financial Results

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it...


Mar 08, 2018, 16:01 ET Kindred Biosciences to Present at the Oppenheimer 28th Annual Healthcare Conference

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will present at the...


Mar 01, 2018, 16:01 ET Kindred Biosciences Announces Fourth Quarter and Full Year 2017 Financial Results

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial...


Feb 15, 2018, 08:30 ET Kindred Biosciences to Announce Fourth Quarter and Year-End 2017 Financial Results

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it...


Feb 13, 2018, 08:30 ET Kindred Biosciences to Participate in the Bank of America Merrill Lynch Animal Health Summit

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will participate in the...


Dec 21, 2017, 08:02 ET KindredBio Announces Submission of European Medicines Agency Filing for Mirataz™

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that the...


Dec 04, 2017, 08:02 ET KindredBio Announces Positive Results from Pivotal Study of Zimeta Oral for Fever in Horses

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced positive...


Nov 07, 2017, 16:01 ET Kindred Biosciences Announces Third Quarter 2017 Financial Results

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial...


Oct 11, 2017, 09:01 ET Kindred Biosciences to Announce Third Quarter 2017 Financial Results

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it...


Oct 05, 2017, 16:01 ET Kindred Biosciences to Participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that Denise...


Sep 11, 2017, 09:00 ET Kindred Biosciences Announces Plans for Promotion of Dr. Zhan and Retirement of Dr. Sundlof

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that Dr....


Aug 30, 2017, 09:02 ET Kindred Biosciences to Present at Upcoming Investor Conferences

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it...


Aug 07, 2017, 16:01 ET Kindred Biosciences Announces Second Quarter 2017 Financial Results

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial...


Aug 04, 2017, 09:02 ET Kindred Biosciences Sponsors Veterinary Students to Attend the 2017 American Association of Feline Practitioners Meeting

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it...


Jul 24, 2017, 09:01 ET Kindred Biosciences to Announce Second Quarter 2017 Financial Results

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it...


Jul 12, 2017, 08:40 ET KindredBio Announces Pricing of Public Offering

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced the pricing...


Jul 11, 2017, 16:10 ET KindredBio Announces Proposed Public Offering of Common Stock

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced a proposed...


Jun 26, 2017, 07:30 ET Kindred Biosciences Announces Acquisition of Kansas Manufacturing Plant and Execution of Commercial Manufacturing Agreement for Zimeta

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it has...


Jun 15, 2017, 08:01 ET Kindred Biosciences Added to the Russell 2000 Index

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it...


May 30, 2017, 09:01 ET Kindred Biosciences to Present Data from Six Studies at the 2017 American College of Veterinary Internal Medicine Conference

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it...


May 24, 2017, 09:01 ET Kindred Biosciences to Present at 7th Annual LD Micro Invitational

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that Denise...


May 03, 2017, 16:01 ET Kindred Biosciences Announces First Quarter 2017 Financial Results

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial...


May 01, 2017, 07:02 ET Kindred Biosciences Announces Initiation of Enrollment in Pivotal Effectiveness Trial of Zimeta Oral for the Control of Fever in Horses

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that the...


Mar 16, 2017, 16:01 ET Kindred Biosciences to Present at 2017 Jefferies Animal Health Summit

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that Dr....


Mar 07, 2017, 08:30 ET Kindred Biosciences Announces Global Sponsorship of International Society of Equine Locomotor Pathology

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, is proud to announce its...